Moncrieff, J;
(2016)
Misrepresenting harms in antidepressant trials.
BMJ
, 352
, Article i217. 10.1136/bmj.i217.
Preview |
Text
Moncrieff_BMJ_editorial_21122015.pdf - Accepted Version Download (107kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Misrepresenting harms in antidepressant trials |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/bmj.i217 |
| Publisher version: | http://doi.org/10.1136/bmj.i217 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, SEROTONIN REUPTAKE INHIBITORS, SUICIDE ATTEMPTS |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10047104 |
Downloads since deposit
178Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
